Skip to main content
Log in

The use of camel antibodies in development of EGFRvIII enzyme-linked immunosorbent assay

  • Published:
Applied Biochemistry and Microbiology Aims and scope Submit manuscript

Abstract

In the present study, anti-EGFRvIII antibodies were purified from the serum of an immunized Arabian camel (Camelus dromedarius). The three subclasses of IgG were purified using protein-G column chromatography. Epidermal growth factor receptor vIII (EGFRvIII) was purified from HC220d2/c cell line expressed the highest levels of EGF receptors using a concanavalin A column chromatography. The ELISA procedure was developed using 2 types of enzyme labels namely horse radish peroxidase (HRP) and penicillinase. The affinity constants of purified total IgG and Ig fractions (IgG1, IgG2 and IgG3) calculated were found to be 4.48 × 107, 1.3 × 107, 4.23 × 106 and 1.67 × 106 M−1, respectively. The sensitivity of assays for the detection of EGFR when used total IgG were found to be 0.35 μg/mL in HRP label assay and 0.45 μg/mL in penicillinase label assay. We concluded that the ELISA in competitive or inhibition manners using polyclonal camel antibodies containing total IgG (but not IgG1, IgG2, and IgG3 fractions) can be promising in detection of EGFRvIII in biological fluids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Harrison, R.A., Cook, D.A., Renjifo, C., Casewell, N.R., Currier, R.B., and Wagstaff, S.C., J. Proteomics, 2011, vol. 74, no. 9, pp. 1768–1780.

    Article  CAS  PubMed  Google Scholar 

  2. Omidfar, K., Moinfar, Z., Sohi, A.N., Tavangar, S.M., Haghpanah, V., Heshmat, R., et al., B., Immunol. Invest., 2009, vol. 38, no. 2, pp. 165–180.

    Article  CAS  Google Scholar 

  3. Rajabibazl, M., Rasaee, M.J., Forouzandeh, M., and Rahimpour, A., Iran. J. Immunol., 2013, vol. 10, no. 4, p. 247.

    Google Scholar 

  4. Saerens, D., Conrath, K., Govaert, J., and Muyldermans, S., J. Mol. Biol., 2008, vol. 377, no. 2, pp. 478–488.

    Article  CAS  PubMed  Google Scholar 

  5. Ebrahimizadeh, W., Gargari, S.M., Rajabibazl, M., Ardekani, L.S., Zare, H., and Bakherad, H., Appl. Microbiol. Biotechnol., 2013, vol. 97, no. 10, pp. 4457–4466.

    Article  CAS  PubMed  Google Scholar 

  6. Revets, H., De Baetselier, P., and Muyldermans, S., Expert Opin. Biol. Ther., 2005, vol. 5, no. 1, pp. 111–124.

    Article  CAS  PubMed  Google Scholar 

  7. Van Bockstaele, F., Holz, J.-B., and Revets, H., Curr. Opin. Investig. Drugs, 2009, vol. 10, no. 11, pp. 1212.

    PubMed  Google Scholar 

  8. Araste, F., Ebrahimizadeh, W., Rasooli, I., Rajabibazl, M., and Gargari, S.L.M., Biotechnol. Lett., 2014, vol. 36, no. 1, pp. 21–28.

    Article  CAS  PubMed  Google Scholar 

  9. Ardekani, L.S., Gargari, S.L.M., Rasooli, I., Bazl, M.R., Mohammadi, M., Ebrahimizadeh, W., et al., Int. J. Infect. Dis., 2013, vol. 17, no. 9, pp. e723–e728.

    Article  CAS  PubMed  Google Scholar 

  10. Payandeh, Z., Rasooli, I., Gargari, S.L.M., Bazl, M.R., and Ebrahimizadeh, W., Trans. R. Soc. Trop. Med. Hyg., 2014, vol. 108, no. 2, pp. 92–98.

    Article  CAS  PubMed  Google Scholar 

  11. Sampson, J.H., Aldape, K.D., Archer, G.E., Coan, A., Desjardins, A., Friedman, R.E., et al., Neuro Oncol., 2011, vol. 13, no. 3, pp. 324–333.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. US Patent No. 20120070848 A1, 2008. http://www.google.com/patents/US20120070848

  13. Schmittling, R.J., Archer, G.E., Mitchell, D.A., Heimberger, A., Pegram, C., Herndon, J.E., et al., J. Immunol. Methods, 2008, vol. 339, no. 1, pp. 74–81.

    Article  CAS  PubMed  Google Scholar 

  14. Ye, F., Gao, Q., Cai, M.-J., and Expert, Opin., Ther. Targets, 2010, vol. 14, no. 3, pp. 303–316.

    Article  CAS  Google Scholar 

  15. Montano, N., Cenci, T., Martini, M., D’Alessandris, Q.G., Pelacchi, F., Ricci-Vitiani, L., et al., Neoplasia (New York, NY), 2011, vol. 13, no. 12, p. 1113.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Denmark Patent No. EP1978103 A1, 2008. https://register.epo.org/application?number=EP07006891

  17. Rajabibazl, M., Javad Rasaee, M., Tiraihi, T., Naderi Sohi, A.R., and Hallaj, S., J. Appl. Res., 2010, vol. 10, no. 3, p. 134.

    CAS  Google Scholar 

  18. Harmsen, M. and De Haard, H., Appl. Microbiol. Biotechnol., 2007, vol. 77, no. 1, pp. 13–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Beatty, J.D., Beatty, B.G., and Vlahos, W.G., J. Immunol. Methods, 1987, vol. 100, no. 1, pp. 173–179.

    Article  CAS  PubMed  Google Scholar 

  20. US Patent No. WO2001068711 A1, 2001. http://www.google.com/patents/WO2001068711A1?cl=en

  21. Yes, X., Hybridoma, 2012, vol. 31, no. 4, p. 301.

    Article  Google Scholar 

  22. Shaker, G.H. and Melake, N.A., Saudi Pharm. J., 2012, vol. 20, no. 3, pp. 221–227.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Rajabibazl.

Additional information

The article is published in the original.

These authors have equal rights regarding this research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sohi, A.N., Rajabibazl, M., Rasaee, M.J. et al. The use of camel antibodies in development of EGFRvIII enzyme-linked immunosorbent assay. Appl Biochem Microbiol 51, 374–380 (2015). https://doi.org/10.1134/S0003683815030163

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0003683815030163

Keywords

Navigation